In the search for P2-receptors modulating the stimulation-evoked entry of calcium at processes of PC12 cells differentiated in the presence of nerve growth factor and neurotrophin-3, electrically evoked increases in free calcium were assessed by fura-2 microfluorimetry. Omission of calcium and addition of cadmium (100 M) or the N-type calcium channel blocker -conotoxin GVIA (0.5 M) abolished or markedly reduced the evoked responses. The P2Y-receptor agonists 2-methylthio adenosine 5Ј-diphosphate (2-methylthio-ADP), ADP, and adenosine 5Ј-O-(2-thiodiphosphate) (ADP␤S) inhibited the electrically evoked entry of calcium without any changes in basal calcium concentrations. 2-Methylthio-ADP was the most potent agonist. Adenosine, P -methyl-2Ј-deoxyadenosine 3Ј,5Ј-bisphosphate; 10 M), as well as the adenosine A 1 -receptor antagonist DPCPX (8-cyclopentyl-1,3-dipropylxanthine; 100 nM), caused no change. Pretreatment with pertussis toxin abolished the effect of ADP␤S. Reverse transcriptase-polymerase chain reaction revealed the presence of mRNA for P2Y12-receptors in nondifferentiated and differentiated PC12 cells. The results indicate that processes of differentiated PC12 cells possess P2Y12-receptors coupling to pertussis toxin-sensitive G-proteins and mediating an inhibition of the stimulation-evoked entry of calcium through -conotoxin GVIA-sensitive calcium channels. This suggests a role of P2Y12-receptors in neuromodulation in addition to their involvement in platelet aggregation.
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,P 4 -di(adenosine-5Ј)-tetraphosphate (Ap4A), UDP, and UTP (30 M each) had no effect. The effect of ADP␤S (30 M) was abolished by the P2-antagonists reactive blue 2 (3 M), suramin (100 M), 2-methylthio-AMP (10 M), p-chloromercuriphenyl sulfonic acid (1 M), and AR-C 69931MX [N 6 -(2-methylthioethyl)-2-(3,3,3-trifluoropropylthio)-␤,␥-dichloromethylene adenosine 5Ј-triphosphate] (300 nM). In contrast, pyridoxalphosphate-6-azophenyl-2Ј,4Ј-disulfonic acid (10 M), the selective P2Y1-receptor antagonist MRS 2179 (N 6 -methyl-2Ј-deoxyadenosine 3Ј,5Ј-bisphosphate; 10 M), as well as the adenosine A 1 -receptor antagonist DPCPX (8-cyclopentyl-1,3-dipropylxanthine; 100 nM), caused no change. Pretreatment with pertussis toxin abolished the effect of ADP␤S. Reverse transcriptase-polymerase chain reaction revealed the presence of mRNA for P2Y12-receptors in nondifferentiated and differentiated PC12 cells. The results indicate that processes of differentiated PC12 cells possess P2Y12-receptors coupling to pertussis toxin-sensitive G-proteins and mediating an inhibition of the stimulation-evoked entry of calcium through -conotoxin GVIA-sensitive calcium channels. This suggests a role of P2Y12-receptors in neuromodulation in addition to their involvement in platelet aggregation.
The operation of P2-receptors inhibiting the release of neurotransmitters has been demonstrated in the peripheral and central nervous system (for reviews see Silinsky et al., 1998; Inoue et al., 1999; von Kü gelgen et al., 1999a) . At postganglionic sympathetic axons the receptors are activated by endogenous adenine nucleotides released as cotransmitters of norepinephrine and, hence, mediate a negative feedback inhibition of sympathetic transmitter release (Fuder and Muth, 1993; von Kü gelgen et al., 1993) . Release-inhibiting P2-receptors have also been found in adrenal chromaffin cells and the cell bodies of rat PC12 cells (Gandia et al., 1993; Currie and Fox, 1996; Powell et al., 2000; Vartian and Boehm, 2001; Unterberger et al., 2002) . The release-inhibiting P2-receptors share some properties with cloned and expressed P2Y1-receptors (for references see above), but their molecular identity is yet not known. In addition to inhibitory P2-receptors, the cell bodies of postganglionic sympathetic neurons, adrenal chromaffin cells, and PC12 cells possess excitatory P2-receptors of distinct subtypes and with distinct signaling transduction pathways (for reviews see Silinsky et al., 1998; von Kü gelgen et al., 1999a ; for PC12 cells see, for example, Arslan et al., 2000; Unterberger et al., 2002) .
The inhibition of calcium channels at axon terminals is a key element in the modulation of transmitter release by inhibitory G-protein-coupled receptors (see Przywara et al., 1993; Mirotznik et al., 2000; Jarvis and Zamponi, 2001 ). Therefore, we searched for P2-receptors modulating the elec- -methyl-2Ј-deoxyadenosine 3Ј,5Ј-bisphosphate; DPCPX, 8-cyclopentyl-1,3-dipropylxanthine; CMPS, p-chloromercuriphenyl sulfonic acid; 2-methylthio-AMP, 2-methylthio adenosine 5Ј-monophosphate; AR-C 69931MX, N 6 -(2-methylthioethyl)-2-(3,3,3-trifluoropropylthio)-␤,␥-dichloromethylene adenosine 5Ј-triphosphate; RB2, reactive blue 2; PPADS, pyridoxalphosphate-6-azophenyl-2Ј,4Ј-disulfonic acid; DMSO, dimethyl sulfoxide.
trically evoked entry of calcium in processes of differentiated PC12 cells. Effects of P2-receptor agonists and antagonists on the electrically evoked increases in free calcium concentration in these processes were assessed by means of fura-2 microfluorimetry to characterize P2-receptor subtypes in this model system. A contribution of different calcium channels to the evoked calcium entry and the possible involvement of pertussis toxin-sensitive G-proteins were also analyzed. Moreover, we searched for the presence of mRNA encoding for the recently cloned P2Y12-receptor in PC12 cells. A part of the results has been presented at a meeting of the Federation of the European Pharmacological Societies (Kulick and von Kü gelgen, 2001 ).
The ratio fluorescence emission due to excitation at 340 nm/fluorescence emission due to excitation at 380 nm (F 340 nm/F 380 nm) was evaluated for estimation of changes in intracellular calcium concentration. Due to the known problems of calibration (see Leipziger et al., 1991) , the values were not transformed in absolute calcium concentrations. Stimulation-evoked increases in the ratio were expressed as the difference fluorescence ratio at peak minus basal ratio (determined by averaging the four ratios obtained before onset of the respective stimulation period). Experiments with a high variability in the responses to the preceding periods of electrical stimulation (difference of a response Ͼ20% from the mean of the three respective responses) were excluded from further evaluation. For the quantification of the experimentally induced changes, the first response to stimulation in the presence of a drug (2 min after addition) was expressed as percentage of the averaged responses to the three preceding stimulation periods (% of preceding responses).
Isolation of poly(A ؉ ) mRNA and RT-PCR. mRNA was isolated from nondifferentiated and differentiated cells cultured as described above, using the Oligotex Direct mRNA Mini Kit (72022; QIAGEN GmbH, Hilden, Germany). The efficiency of the isolation was proofed by the demonstration of mRNA for ␤-actin. Reverse transcriptase-polymerase chain reaction (RT-PCR) was performed using gene-specific primers for the rat P2Y12 receptor (sense primer: CACCATGGAGGT-GCCTGGTGCCAAC; antisense primer: CATTGGGGTCTCCTCGCTT-GGGTC) and ␤-actin (sense: GTACCCCATTGAACACGGCATTG; antisense: GTCACGCACGATTTCCCTCTCAG) and the Superscript One
Step RT-PCR kit (Invitrogen). Annealing temperature for the PCR reaction was 67.7°C (30 cycles) in the case of the undifferentiated PC12 cells and 66°C (45 cycles) in the case of the differentiated PC12 cells Fig. 1 . Processes of differentiated PC12 cells and effects of electrical stimulation and -conotoxin GVIA on intracellular calcium concentration. Cells were treated with nerve growth factor-␤ (40 ng/ml) and neurotrophin-3 (10 ng/ml) for 12 days and incubated with fura-2 AM (2 M). A, phase-contrast image; bar, 20 m. The arrow points to the area evaluated in C. B, digital image of fura-2 fluorescence after excitation at 360 nm. C, cells were stimulated by periods of 10 pulses applied at 100 Hz (10 p/100 Hz). After three preceding periods of stimulation, -conotoxin GVIA was added to the superfusion medium for 6 min. The figure shows the fura-2 fluorescence ratio F 340 nm/F 380 nm, measured as an estimate of the intracellular calcium concentration in one of six observations.
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at ASPET Journals on July 10, 2017 jpet.aspetjournals.org when amplifying the mRNA for the P2Y12 receptor and ␤-actin. For control experiments the enzyme reverse transcriptase was omitted (instead of the RT-PCR enzyme mix, Taq Platinum Polymerase was used; 10966, Invitrogen). PCR products were analyzed by ethidium bromide staining after agarose (0.9%) gel electrophoresis. The product of one RT-PCR reaction with primers for the P2Y12 receptor was cloned into the expression vector pcDNA3.1D/V5-His-TOPO (Invitrogen). The sequence was identified by cycle sequencing (Thermo Sequenase fluorescent labeled primer cycle sequencing kit; Amersham Biosciences UK, Ltd., Little Chalfont, Buckinghamshire, UK) using a LICOR Gene READIR 4200 sequencer (MWG-Biotech, Ebersberg, Germany).
Materials. The following drugs were used: adenosine 5Ј-triphosphate disodium (ATP), adenosine 5Ј-diphosphate sodium (ADP), adenosine 5Ј-O-(2-thiodiphosphate) trilithium (ADP␤S), 2-methylthio adenosine 5Ј-diphosphate trisodium (2-methylthio-ADP), adenosine, P 1 ,P 4 -di(adenosine-5Ј)-tetraphosphate ammonium (Ap4A), uridine 5Ј-diphosphate sodium (UDP), uridine 5Ј-triphosphate trisodium (UTP), N 6 -methyl 2Ј-deoxyadenosine 3Ј,5Ј-bisphosphate diammonium (MRS 2179), 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), p-chloromercuriphenyl sulfonic acid (CMPS), 2-methylthio adenosine 5Ј-monophosphate triethylammonium (2-methylthio-AMP), pertussis toxin, nifedipine, cadmium chloride (Sigma), -agatoxin IVa (Bachem, Heidelberg, Germany), -conotoxin GVIA (Alamone, Jerusalem, Israel, or Bachem), N 6 -(2-methylthioethyl)-2-(3,3,3-trifluoropropylthio)-␤,␥-dichloromethylene adenosine 5Ј-triphosphate (AR-C 69931MX; Astra, Hä ssle, Mölndal, Sweden), reactive blue 2 (RB2; Ega-Chemie, Steinheim, Germany), suramin (Bayer, Leverkusen, Germany), and pyridoxalphosphate-6-azophenyl-2Ј,4Ј-disulfonic acid (PPADS; Tocris Cookson, Southampton, UK). Stock solutions of drugs were prepared with distilled water or (nifedipine, CMPS, DPCPX) with dimethyl sulfoxide (DMSO; Sigma). DMSO (0.01%) was added to the buffer used for control experiments for nifedipine, CMPS, and DPCPX. For pertussis toxin control experiments the solvents present in the purchased solution were added to the medium [final concentration: 0.05% glycerol (Serva, Heidelberg, Germany), 0.5 mM NaCl, 0.05 mM Trizma-Base (Sigma), and 0.38 mM glycine (Merck, Darmstadt, Germany)].
Statistics. Results are presented as means Ϯ S.E. from n observations (evaluated processes; one process per analyzed cell). Except when stated otherwise, differences between means were tested for significance by Student's t test or (for multiple comparisons with the same control) by an analysis of variance (ANOVA) followed by the Bonferroni's multiple comparison test (Prism, GraphPad, San Diego CA). P Ͻ 0.05 or lower was the significance criterion.
Results
PC12 cells were plated on coverslips coated with poly(Llysine) and Matrigel and cultured in the presence of nerve growth factor-␤ (40 ng/ml) and neurotrophin-3 (10 ng/ml) for up to 18 days. After about 6 days in culture, the cells developed long and multiple processes as shown in Fig. 1, A and B. fura-2 fluorescence was measured as an estimate of changes in intracellular calcium concentration. After incubation with fura-2 AM, fluorescence was observed not only in cell bodies (not shown) but also in the processes (Fig. 1B) . One area of one process was evaluated per cell (see marked area in Fig.  1A ). Electrical stimulation by square pulses (0.3 ms) caused transient increases in the fura-2 fluorescence ratio (Fig. 1C ) dependent on the number of pulses applied (not shown). When the preparations were stimulated by periods of 10 pulses/100 Hz applied every 3 min, the responses were well reproducible (Fig. 1C) . In the absence of drugs, the response to a fourth period of stimulation amounted to 106.9% of the averaged responses to the three preceding periods (control; see legend to Table 1 ). On average, a preceding period of stimulation caused an increase in the fura-2 fluorescence ratio by 64.0 Ϯ 4.1% above baseline (n ϭ 180).
Effects of Calcium Channel Blockers. Omission of calcium from the superfusion buffer abolished the response to electrical stimulation (reduction by 92.6 Ϯ 2.4%; n ϭ 5; P Ͻ 0.01). To study the contribution of voltage-dependent calcium channels to the evoked increase in calcium concentration, effects of several channel blockers were tested. Cadmium (100 M) as well as the N-type calcium channel blocker -conotoxin GVIA (0.5 M; Hirning et al., 1988) markedly reduced the responses to stimulation (Fig. 1C and Table 1) , whereas the L-type calcium channel blocker nifedipine (10 M) and the P/Q-type calcium channel blocker -agatoxin The table shows the statistical evaluation of the responses 2 min after addition of the compounds (i.e., the responses to the fourth period of stimulation as shown in Fig. 1C ). Responses were first expressed as percentage of the averaged responses to the three preceding periods of stimulation. These values were then normalized with respect to the mean of the corresponding control group (percentage of respective control; mean value in the control group: 106.9 Ϯ 3.3% of averaged preceding responses; control plus DMSO: 100.9 Ϯ 5.4%). Values are means Ϯ S.E. of n ϭ 5 to 24. Mintz et al., 1992) failed to alter the responses (Table 1) . None of the compounds changed basal fluorescence ratios (not shown). Effects of Adenosine and Nucleotides. Next, the effects of P1-and P2-receptor agonists were analyzed. The P2Y-receptor agonist ADP␤S (Ralevic and Burnstock, 1998) has previously been shown to cause a preferential activation of presynaptic P2-receptors (see von Kü gelgen et al., 1999a) . When used in the present study on processes of differentiated PC12 cells at a concentration of 30 M, ADP␤S attenuated the electrically evoked responses by 51%, 2 min after addition of the compound ( Figs. 2A and 3) . On average, the inhibitory effect of ADP␤S (30 M) was smaller when the compound was present for an additional period of 3 min (i.e., for two periods of stimulation; inhibition by 34.4 Ϯ 5.6%, n ϭ 11; P Ͻ 0.01, paired t test; e.g., Fig. 2A ). For this reason, effects observed 2 min after addition of drugs were analyzed in the present study. The inhibition by ADP␤S was reversible after removal of the compound from the superfusion buffer ( Fig. 2A) and dependent on the concentration used (Fig. 3) . ADP and 2-methylthio-ADP, agonists at the P2Y1-, P2Y12-, and P2Y13-receptors (von Kü gelgen and Wetter 2000; Communi et al., 2001; Hollopeter et al., 2001; Zhang et al., 2001) , also caused an inhibition of the electrically induced increases in fura-2 fluorescence (Fig. 3) . 2-Methylthio-ADP was the most potent compound followed by ADP and ADP␤S. In contrast to the adenine nucleotides tested, both the diadenine nucleotide Ap4A, an agonist at the rat P2Y2-and P2Y4-receptors (von Kü gelgen and Wetter, 2000) , and the P1-purinoceptor agonist adenosine failed to change the electrically evoked responses (each compound tested at 30 M; Fig. 3 ). The same was true for the uracil nucleotides UDP (30 M; Fig. 3 ) and UTP (evoked response in the presence of 30 M: 95.0 Ϯ 2.4% of control, n ϭ 7). UDP and UTP are known to activate the P2Y2-, P2Y4-, and P2Y6-receptors (Nicholas et al., 1996) . None of the compounds described above affected the basal fluorescence ratio. However, ATP (30 M), which activates P2X-receptors in addition to P2Y-receptors (North and Barnard, 1997; Ralevic and Burnstock, 1998; Nörenberg and Illes, 2000) , increased the basal ratio by 49.5 Ϯ 21.6% (n ϭ 5, P Ͻ 0.01). This increase is likely to be due to a P2X-receptor-mediated influx of calcium (see Arslan et al., 2000; Nörenberg and Illes, 2000) . ATP also tended to reduce the electrically evoked responses in the present study on processes of PC12 cells, but the effect was not further analyzed due to the marked increase in basal ratio, which makes the determination of electrically evoked responses unreliable.
Interaction with Purinoceptor Antagonists. Antagonists were given 18 min before the agonist ADP␤S (30 M). DPCPX used at a concentration (0.1 M) about 200 times its affinity constant at the adenosine A 1 -receptor (Lohse et al., 1987) did not affect the inhibitory action of ADP␤S (Fig. 4) . In contrast, reactive blue 2 (RB2, 3 M) and suramin (100 M), both of which block a number of P2-receptor subtypes, abolished the inhibitory effect of ADP␤S. The P2-antagonist PPADS, known to effectively block P2Y1-receptors in addition to several P2X-subtypes (Lambrecht, 2000; von Kü gelgen and Wetter, 2000) , had no significant effect when used at a concentration of 10 M.
In addition to reactive blue 2, suramin, and PPADS, four P2-antagonists with a higher selectivity for distinct receptor subtypes were tested. The preferential P2Y1-receptor antagonist MRS 2179, used at 10 M (about 100 times its affinity constant at the P2Y1-receptor; Boyer et al., 1998) , failed to alter the effect of ADP␤S. In contrast, CMPS (1 M), 2-methylthio-AMP (10 M), and AR-C 69931MX (300 nM), all of which have been shown to block the recently cloned P2Y12-receptor (Hollopeter et al., 2001; Takasaki et al., 2001) , abolished the action of ADP␤S (Fig. 4) . None of the antagonists themselves changed the basal fluorescence ratio or the electrically evoked responses (not shown). Presence of mRNA for P2Y12-Receptors in PC12 Cells. RT-PCR with primers specific for the coding sequence of the rat P2Y12-receptor revealed products of the expected length from two mRNA preparations of nondifferentiated PC12 cells (not shown). Control reactions without the enzyme reverse transcriptase showed no products, confirming that mRNA but not genomic DNA acted as a template for the PCR reaction. Cycle sequencing of one RT-PCR reaction product confirmed the identity of the sequence with that of the cloned rat P2Y12-receptor (Hollopeter et al., 2001 ; GenBank accession code AF313450). When using three mRNA preparations from differentiated PC12 cells cultured on coverslips in the presence of nerve growth factor-␤ and neurotrophin-3 (see Materials and Methods), similar results were obtained (Fig. 5) .
Discussion
In the present study we searched for P2-receptors inhibiting the influx of calcium via voltage-dependent calcium channels in processes of differentiated PC12 cells. Changes in the concentration of calcium in the processes were assessed by fura-2 microfluorimetry. Due to the known problems of calibration (Leipziger et al., 1991) , fura-2 fluorescence ratios (F 340 nm/F 380 nm) instead of absolute concentrations of calcium were statistically evaluated.
Electrically Evoked Calcium Entry through N-Type Calcium Channels. Electrical field stimulation of the preparations induced an influx of calcium in the processes through voltage-dependent calcium channels as shown by the blockade of the responses by either omission of calcium from the buffer or addition of cadmium to the buffer. The evoked increase in calcium concentration was also markedly affected by -conotoxin GVIA, but not by nifedipine or -agatoxin IVa, indicating that the increase was at least predominantly mediated by an influx of calcium ions through N-type (Ca v 2.2; Ertel et al., 2000) calcium channels (for references, see above). N-type calcium channels also play the predominant role in stimulation-evoked calcium entry in postganglionic sympathetic neurons (e.g., Hirning et al., 1988; von Kü gelgen et al., 1999b) . In contrast, in adrenal chromaffin cells and cell bodies of PC12 cells, L-type and P/Q-type channels are involved in addition to the N-type channels in the evoked entry of calcium (Liu et al., 1996; Lukyanetz and Neher, 1999) .
Inhibitory P2Y12-Like Receptors Coupling to Pertussis Toxin-Sensitive G-Proteins. The present study demonstrates the operation of P2Y12-like receptors inhibiting the electrically evoked entry of calcium in processes of differentiated PC12 cells. The preferential P2Y-receptor agonists ADP␤S, ADP, and 2-methylthio-ADP inhibited the evoked entry of calcium in a concentration-dependent manner. The receptor involved in the inhibition of calcium entry at the processes of PC12 cells is not an adenosine receptor, but a P2-receptor, as shown by: 1) the lack of any effect of adenosine, 2) the failure of the adenosine A 1 -receptor antagonist DPCPX to alter the effect of ADP␤S, and 3) the blockade of the effect of ADP␤S by several P2-receptor antagonists including the selective P2Y-antagonist AR-C 69931MX. These findings also exclude an involvement of the recently described heteromers of adenosine A 1 -receptors and P2Y1-receptors (Yoshioka et al., 2001) or the putative P3-purinoceptors (Shinozuka et al., 1988) since both the heteromers, and P3-purinoceptors have been found to be sensitive to the blockade by xanthine derivatives such as DPCPX.
Which subtype of P2-receptor mediates the inhibitory effect? P2X-receptors are ligand-gated ion channels, whereas P2Y-receptors belong to the family of G-protein-coupled receptors (North and Barnard, 1997; Ralevic and Burnstock, 1998) . The blockade of the effect of ADP␤S by the treatment of the cells with pertussis toxin indicates that the receptors couple to G i/o -proteins and clearly identifies the receptors as P2Y-receptors. The lack of any effect of UDP, UTP, and Ap4A excludes the involvement of P2Y2-, P2Y4-, and P2Y6-receptors (for review see Ralevic and Burnstock, 1998; von Kü gelgen and Wetter, 2000) . The action of the diphosphate nucleotides ADP␤S, ADP, and 2-methylthio-ADP is compatible with an involvement of a diphosphate nucleotide preferring P2Y-receptor, i.e., the P2Y1-, P2Y12-, or P2Y13-receptor (Ralevic and Burnstock, 1998; von Kü gelgen and Wetter, 2000; Communi et al., 2001; Hollopeter et al., 2001) , but argues against an involvement of the triphosphate nucleotide preferring P2Y11-receptor (Communi et al., 1997) . The lack of any interaction of ADP␤S with the preferential P2Y1-receptor antagonist MRS 2179 (Boyer et al., 1998) excludes a characterization as P2Y1-receptor. Moreover, the blockade of the effect of ADP␤S by p-chloromercuriphenyl sulfonic acid and 2-methylthio-AMP, as well as AR-C 69931MX, used at a nanomolar concentration strongly suggests the characterization as P2Y12-receptor since these antagonists have previously been shown to block the cloned and expressed P2Y12-receptor (Hollopeter et al., 2001; Takasaki et al., 2001 ). This view is further confirmed by the observation that both the cloned and expressed P2Y12-receptor as well as the inhibitory P2Y-receptor at processes of PC12 cells studied in the present experiments were sensitive to the blockade by suramin and reactive blue 2 but not by PPADS (see Fig. 4 of the present article and Fig. 3A of Takasaki et al., 2001) . The cloned and expressed P2Y12-receptor has been shown to couple to a pertussis toxin-sensitive G-protein (Hollopeter et al., 2001; Zhang et al., 2001) . The same appears to be true for the inhibitory P2Y-receptor in PC12 cells in agreement with a characterization of this receptor as P2Y12. Due to the fact that the pharmacology of the recently cloned human P2Y13-receptor is yet not well defined (and that the rat ortholog of this receptor has yet not been cloned), an additional contribution of a P2Y13-receptor to the observed effects cannot be excluded.
The properties of the inhibitory P2Y12-like receptors found in the present study at the processes of differentiated PC12 cells seem to be very similar to or identical with those of release-inhibiting P2-receptors operating in the peripheral and central nervous system as well as at adrenal chromaffin cells or the cell bodies of PC12 cells (for references, see the introduction). When tested in these studies, ADP, ADP␤S, 2-methylthio-ADP, and ATP acted as agonists, whereas uracil nucleotides were ineffective (for references, see the introduction). Other common features are the blockade by the antagonists suramin and reactive blue 2 as well as by pretreatment with pertussis toxin. Moreover, in a very recent study published during the preparation of this article, the P2-receptors inhibiting adenylyl cyclase activity in PC12 cells were characterized as P2Y12-receptors (Unterberger et al., 2002) . Similarly, as in our study, 2-methylthio-ADP was more potent than ADP in inhibiting adenylyl cyclase activity, and the agonist-induced inhibition was blocked by the antagonists 2-methylthio-AMP and reactive blue 2 but not by PPADS. In contrast to our results and to the results obtained by Takasaki et al. (2001) at the cloned and expressed P2Y12-receptor, suramin (100 M) failed to act as an antagonist at the receptor inhibiting adenylyl cyclase activity (Unterberger et al., 2002) . The reason for the difference is not known.
Except for ATP, which is likely to activate P2X-receptors, none of the nucleotides tested caused an increase in basal calcium concentration in the processes of the PC12 cells (see Results and Fig. 2) . Hence, the processes appear to possess no excitatory P2Y-receptors, which have previously been shown to operate at the cell bodies of PC12 cells and which are sensitive to UTP in addition to ATP (see, for example, Arslan et al., 2000) .
Presence of mRNA for P2Y12-Receptors in PC12 Cells. In agreement with the idea that PC12 cells express P2Y12-receptors, RT-PCR experiments using poly(A ϩ ) mRNA preparations from nondifferentiated and differentiated PC12 cells showed the presence of mRNA for the full coding sequence of the P2Y12-receptor, compatible with an expression of these receptors in PC12 cells.
A Role for P2Y12-Receptors as Inhibitory Receptors in the Nervous System? P2Y12-receptors have been cloned from platelets (Hollopeter et al., 2001 ) and have been identified as one of the P2-receptors involved in ADP-induced platelet aggregation (Hollopeter et al., 2001; Takasaki et al., 2001; Zhang et al., 2001 ). The present results suggest an additional functional role for P2Y12-receptors: a role as inhibitory receptors operating at neuronal cells. Since mRNA for P2Y12-receptors seems to be abundantly expressed in the brain (Hollopeter et al., 2001; Takasaki et al., 2001; Zhang et al., 2001) , the role of P2Y12-receptors as inhibitory receptors in the nervous system may be widespread. A recent study using guanosine 5Ј-O-(3-[
35 S]thio)triphosphate autoradiography on rat brain sections also showed evidence for the operation of a receptor similar to the platelet ADP receptor in the gray and white matter of the forebrain and brainstem (Laitinen et al., 2001 ).
The present results indicate that P2Y12-receptors mediate inhibitory effects of adenine nucleotides at processes of PC12 cells. Remaining questions are whether P2Y12-receptors or distinct P2Y-subtypes such as the P2Y1-receptor or the P2Y13-receptor are involved in neuromodulation at peripheral and central neurons and whether the receptors couple to calcium or potassium channels (cf. Ferná ndez-Ferná ndez et al., 2001) .
Conclusions
The present study directly demonstrates the operation of inhibitory P2Y-receptors at neuronal processes. The receptors mediate an inhibition of the stimulation-evoked entry of calcium through N-type calcium channels. The properties of the receptors suggest a characterization as P2Y12-receptors.
